Literature DB >> 6188863

Functional basis of poliovirus neutralization determined with monospecific neutralizing antibodies.

E A Emini, S Y Kao, A J Lewis, R Crainic, E Wimmer.   

Abstract

Antibody-mediated poliovirus neutralization was studied by using a series of 13 monospecific neutralizing antibodies. These antibodies were found to recognize seven individual viral epitopes, several of which functionally overlap one another. Each epitope was capable of undergoing variation so that the variant virus was no longer capable of being neutralized by antibody directed against that epitope. The measured degree of variation for each site varied from -3.1 to -4.2 log10 variant PFU per wild-type PFU. Under nonsaturating but neutralizing conditions, the antibodies, with the exception of those directed to one specific epitope, failed to completely inhibit the virion's binding to the cell. Similarly, none of the neutralizing antibodies completely inhibited viral penetration, but all prevented virus-specific transcription. A strong correlation was established between the binding of each of the neutralizing antibodies, with one exception, to the virion and a significant shift in the virion's pI from 7.0 to ca. 4.0.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6188863      PMCID: PMC255148     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  23 in total

1.  Continuous cultures of fused cells secreting antibody of predefined specificity.

Authors:  G Köhler; C Milstein
Journal:  Nature       Date:  1975-08-07       Impact factor: 49.962

2.  Early alteration of poliovirus in infected cells and its specific inhibition.

Authors:  K Lonberg-Holm; L B Gosser; J C Kauer
Journal:  J Gen Virol       Date:  1975-06       Impact factor: 3.891

3.  Neutralization of poliovirus: a hypothesis to explain the mechanism and the one-hit character of the neutralization reaction.

Authors:  B Mandel
Journal:  Virology       Date:  1976-02       Impact factor: 3.616

4.  Characterization of type 1 poliovirus by electrophoretic analysis.

Authors:  B Mandel
Journal:  Virology       Date:  1971-06       Impact factor: 3.616

5.  The interaction of neutralized poliovirus with HeLa cells. I. Adsorption.

Authors:  B Mandel
Journal:  Virology       Date:  1967-02       Impact factor: 3.616

6.  A neutralizing monoclonal antibody against poliovirus and its reaction with related antigens.

Authors:  J Icenogle; S F Gilbert; J Grieves; J Anderegg; R Rueckert
Journal:  Virology       Date:  1981-11       Impact factor: 3.616

7.  Primary structure, gene organization and polypeptide expression of poliovirus RNA.

Authors:  N Kitamura; B L Semler; P G Rothberg; G R Larsen; C J Adler; A J Dorner; E A Emini; R Hanecak; J J Lee; S van der Werf; C W Anderson; E Wimmer
Journal:  Nature       Date:  1981-06-18       Impact factor: 49.962

8.  Derivation of specific antibody-producing tissue culture and tumor lines by cell fusion.

Authors:  G Köhler; C Milstein
Journal:  Eur J Immunol       Date:  1976-07       Impact factor: 5.532

9.  Multiple genetic changes can occur in the oral poliovaccines upon replication in humans.

Authors:  O M Kew; B K Nottay; M H Hatch; J H Nakano; J F Obijeski
Journal:  J Gen Virol       Date:  1981-10       Impact factor: 3.891

10.  A hybridoma cell line secreting antibody to poliovirus type 3 D-antigen: detection in virus harvest of two D-antigen populations.

Authors:  M Ferguson; G C Schild; P D Minor; P J Yates; M Spitz
Journal:  J Gen Virol       Date:  1981-06       Impact factor: 3.891

View more
  40 in total

1.  Regulation of virus neutralization and the persistent fraction by TRIM21.

Authors:  W A McEwan; F Hauler; C R Williams; S R Bidgood; D L Mallery; R A Crowther; L C James
Journal:  J Virol       Date:  2012-05-30       Impact factor: 5.103

2.  The synergistic neutralization of Rift Valley fever virus by monoclonal antibodies to the envelope glycoproteins.

Authors:  T G Besselaar; N K Blackburn
Journal:  Arch Virol       Date:  1992       Impact factor: 2.574

3.  Mutations conferring resistance to neutralization with monoclonal antibodies in type 1 poliovirus can be located outside or inside the antibody-binding site.

Authors:  B Blondel; R Crainic; O Fichot; G Dufraisse; A Candrea; D Diamond; M Girard; F Horaud
Journal:  J Virol       Date:  1986-01       Impact factor: 5.103

4.  Capsid intermediates assembled in a foot-and-mouth disease virus genome RNA-programmed cell-free translation system and in infected cells.

Authors:  M J Grubman; D O Morgan; J Kendall; B Baxt
Journal:  J Virol       Date:  1985-10       Impact factor: 5.103

5.  Different virus-precipitating activities of neutralizing monoclonal antibodies that recognize distinct sites of poliovirus particles.

Authors:  K Taniguchi; S Urasawa
Journal:  Arch Virol       Date:  1987       Impact factor: 2.574

6.  Very high frequency of reversion to guanidine resistance in clonal pools of guanidine-dependent type 1 poliovirus.

Authors:  J C de la Torre; E Wimmer; J J Holland
Journal:  J Virol       Date:  1990-02       Impact factor: 5.103

7.  Destabilization of herpes simplex virus type 1 virions by local anesthetics, alkaline pH, and calcium depletion.

Authors:  K Yanagi; S Harada
Journal:  Arch Virol       Date:  1989       Impact factor: 2.574

8.  Molecular pathogenesis of type 2 poliovirus in mice.

Authors:  T Couderc; B Guinguene; F Horaud; A Aubert-Combiescu; R Crainic
Journal:  Eur J Epidemiol       Date:  1989-09       Impact factor: 8.082

9.  Viral multiplicity of attachment and its implications for human immunodeficiency virus therapies.

Authors:  J L Spouge
Journal:  J Virol       Date:  1994-03       Impact factor: 5.103

10.  Neutralization of adenoviruses: kinetics, stoichiometry, and mechanisms.

Authors:  C Wohlfart
Journal:  J Virol       Date:  1988-07       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.